Listed

Enveric Biosciences, Inc.

ENVBNasdaqCIK 890821HealthcareFiscal year ends Dec 31

Reports and events: 398 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Enveric Biosciences, Inc., Reports and events
FiledFormWhat it isAccession number
2020-08-1217:28 ET10-K/AAnnual report, amendedPeriod 2019-12-310001493152-20-015385
2020-08-1217:19 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-20-015383
2020-08-0308:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-20-014442
2020-06-0409:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-010535
2020-06-0108:00 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-20-010211
2020-05-1508:32 ET10-QQuarterly reportPeriod 2020-03-310001567619-20-010243
2020-05-0613:29 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001140361-20-010802
2020-03-2516:16 ET10-KAnnual reportPeriod 2019-12-310001140361-20-006825
2020-03-0416:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001140361-20-004807
2020-01-1308:05 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-20-000667
2019-12-1307:55 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-19-022483
2019-11-2608:00 ET8-K/A9.01 Financial statements and exhibits0001140361-19-021424
2019-11-2507:28 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001140361-19-021278
2019-11-2216:15 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-19-021241
2019-11-0816:09 ET8-K5.07 Shareholder vote results0001140361-19-020188
2019-11-0816:07 ET10-QQuarterly reportPeriod 2019-09-300001140361-19-020187
2019-10-3106:43 ET8-K/A8.01 Other events; 9.01 Financial statements and exhibits0001140361-19-019466
2019-10-3016:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-19-019436
2019-09-2718:15 ETDEF 14AProxy statementPeriod 2019-10-290001140361-19-017341
2019-09-2008:35 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-19-017014
2019-08-2616:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-19-015609
2019-08-1406:04 ET10-QQuarterly reportPeriod 2019-06-300001140361-19-014987
2019-06-1708:00 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001140361-19-011110
2019-05-1408:07 ET10-QQuarterly reportPeriod 2019-03-310001140361-19-009043
2019-04-3016:01 ET10-K/AAnnual report, amendedPeriod 2018-12-310001140361-19-008009
2019-04-0216:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001140361-19-006316
2019-03-2606:04 ET10-KAnnual reportPeriod 2018-12-310001140361-19-005573
2019-02-2212:51 ETSC 13D/AOwnership report, active investor, amended0001607062-19-000082
2019-02-1416:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001140361-19-003195
2019-01-2517:26 ETSC 13D/AOwnership report, active investor, amended0000921895-19-000155
2019-01-2515:55 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001140361-19-001586
2018-12-1406:03 ET8-K3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001140361-18-045141
2018-11-2113:10 ETSC 13D/AOwnership report, active investor, amended0001607062-18-000455
2018-11-1617:07 ETSC 13D/AOwnership report, active investor, amended0000921895-18-003084
2018-11-1518:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000921895-18-003066
2018-11-1417:01 ET10-QQuarterly reportPeriod 2018-09-300001140361-18-043114
2018-11-1316:53 ETS-1Registration statement0001140361-18-042978
2018-11-0813:50 ETSC 13DOwnership report, active investor0001607062-18-000396
2018-11-0813:49 ETSC 13DOwnership report, active investor0001607062-18-000394
2018-11-0813:48 ETSC 13DOwnership report, active investor0001607062-18-000392
2018-11-0813:46 ETSC 13DOwnership report, active investor0001607062-18-000390
2018-10-2310:12 ETS-1/ARegistration statement, amended0001140361-18-041092
2018-10-2210:54 ETS-1/ARegistration statement, amended0001140361-18-040993
2018-10-1717:21 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000921895-18-002791
2018-10-0516:23 ET8-K1.02 Termination of a material agreement; 2.04 Item not in the standard list0000921895-18-002711
2018-09-2716:03 ET8-K5.07 Shareholder vote results0000921895-18-002661
2018-09-2517:15 ETS-1/ARegistration statement, amended0001140361-18-039056
2018-08-3116:23 ET8-K1.02 Termination of a material agreement; 2.04 Item not in the standard list0000921895-18-002523
2018-08-2416:39 ETS-1Registration statement0001140361-18-036924
2018-08-2216:44 ETDEF 14AProxy statementPeriod 2018-08-100000921895-18-002453

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.